• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈筛查指南改变对女性接受检查的年龄和间隔的影响:基于人群的研究。

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study.

机构信息

School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Public Health England Screening, Screening Quality Assurance Service, Birmingham, UK.

出版信息

J Med Screen. 2021 Sep;28(3):325-332. doi: 10.1177/0969141320953446. Epub 2020 Aug 30.

DOI:10.1177/0969141320953446
PMID:32862772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8366121/
Abstract

BACKGROUND

English cervical screening programme guidelines changed between 2009 and 2012. We explore the impact on the age and intervals at which women receive a cytology test.

METHODS

Eligible women were controls from a population-based case-control study in England. Tests taken between 1980 and 2017 were extracted from the call/recall database. Using the Kaplan-Meier estimator by birth cohort and age at (or time since) last test, we explore proportions tested since or prior to a given age, years since previous test, and interval following a negative test.

RESULTS

Screening histories from 46,037 women were included. Proportion tested by age 26 has increased from 55% among birth cohorts 1978-1979 to 67% among those born 1990-1991, despite more recent cohorts only having received one invitation (instead of two) prior to age 26. The proportion of women tested at aged 28 with a test three years earlier increased by 20% (from 36% in 1997-2006 to 56% in 2012-2017) whereas the proportion tested at ages 23-27 without a prior test increased from 34% to 80%. The age at last test prior to exiting the programme has decreased: among those born 1928-1931 86% had a test aged 60-65, but only 71% of those born 1947-1951.

CONCLUSION

Clear programme guidance alongside quality assurance has improved the cervical screening programme by standardising the age and intervals at which women are screened.

摘要

背景

2009 年至 2012 年间,英国宫颈筛查项目指南发生了变化。我们探讨了这对女性接受细胞学检查的年龄和间隔的影响。

方法

合格的女性是来自英格兰基于人群的病例对照研究的对照者。从呼叫/召回数据库中提取了 1980 年至 2017 年间进行的检测。按出生队列和上次检测时的年龄(或距上次检测的时间)使用 Kaplan-Meier 估计器,我们探讨了在特定年龄之前或之后接受检测的比例、上次检测后的年数以及阴性检测后的间隔。

结果

共纳入了 46037 名女性的筛查史。尽管最近的队列在 26 岁之前只收到一次邀请(而不是两次),但出生队列 1978-1979 年的 26 岁前接受检测的比例从 55%增加到了 1990-1991 年的 67%。28 岁时进行的检查比例增加了 20%(从 1997-2006 年的 36%增加到 2012-2017 年的 56%),而未经前次检查在 23-27 岁之间进行检查的比例从 34%增加到 80%。退出项目前最后一次检测的年龄已经下降:出生于 1928-1931 年的人中有 86%在 60-65 岁时接受了检测,但出生于 1947-1951 年的人中只有 71%接受了检测。

结论

明确的项目指导和质量保证通过标准化女性接受筛查的年龄和间隔,改善了宫颈筛查项目。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/3f9a050f29ba/10.1177_0969141320953446-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/980868a1875a/10.1177_0969141320953446-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/3be7cc49924b/10.1177_0969141320953446-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/9bea7e966b7f/10.1177_0969141320953446-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/8a1ff2716aac/10.1177_0969141320953446-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/9ff001727c62/10.1177_0969141320953446-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/3f9a050f29ba/10.1177_0969141320953446-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/980868a1875a/10.1177_0969141320953446-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/3be7cc49924b/10.1177_0969141320953446-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/9bea7e966b7f/10.1177_0969141320953446-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/8a1ff2716aac/10.1177_0969141320953446-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/9ff001727c62/10.1177_0969141320953446-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0d/8366121/3f9a050f29ba/10.1177_0969141320953446-fig6.jpg

相似文献

1
Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study.宫颈筛查指南改变对女性接受检查的年龄和间隔的影响:基于人群的研究。
J Med Screen. 2021 Sep;28(3):325-332. doi: 10.1177/0969141320953446. Epub 2020 Aug 30.
2
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.英格兰原发性人乳头瘤病毒子宫颈筛查的临床效果和成本效益:通过三轮筛查对 ARTISTIC 随机试验队列进行的扩展随访。
Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.
3
HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.HPV 检测与常规细胞学检查在宫颈癌筛查中的比较:ARTISTIC RCT 的长期随访。
Health Technol Assess. 2019 Jun;23(28):1-44. doi: 10.3310/hta23280.
4
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].[卫生技术评估报告:基于人乳头瘤病毒DNA的宫颈癌前病变初筛]
Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72.
5
Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.在未接种 HPV 疫苗且 HPV 阴性的老年女性中,最后一次筛查的年龄与宫颈癌剩余终生风险:一项建模研究。
Lancet Oncol. 2018 Dec;19(12):1569-1578. doi: 10.1016/S1470-2045(18)30536-9. Epub 2018 Nov 1.
6
Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study.60-64 岁筛查对 50-59 岁筛查史者 84 岁累积宫颈癌发生率的影响:基于人群的病例对照研究。
Prev Med. 2021 Aug;149:106625. doi: 10.1016/j.ypmed.2021.106625. Epub 2021 May 19.
7
Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data.以人乳头瘤病毒检测为基础的宫颈癌筛查间隔时间的延长:英国筛查试点数据的观察性研究。
BMJ. 2022 May 31;377:e068776. doi: 10.1136/bmj-2021-068776.
8
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.高危型人乳头瘤病毒检测的宫颈癌筛查项目中,筛查间隔超过 5 年的安全性:荷兰基于人群的随机队列 14 年随访。
BMJ. 2016 Oct 4;355:i4924. doi: 10.1136/bmj.i4924.
9
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.波兰基于人群的宫颈癌筛查项目中的 HPV 检测(HIPPO 项目)——一项随机医疗政策试验的研究方案。
BMC Cancer. 2023 Nov 17;23(1):1118. doi: 10.1186/s12885-023-11597-5.
10
HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.人乳头瘤病毒免疫接种与宫颈癌筛查——免疫接种女性中作为筛查检测的细胞学检查性能变化的确认:一项基于人群的回顾性队列研究
Br J Cancer. 2016 Mar 1;114(5):582-9. doi: 10.1038/bjc.2015.474. Epub 2016 Feb 4.

引用本文的文献

1
Association between HPV vaccination and cervical screening policy changes and cervical cancer incidence and grade-3 cervical intraepithelial neoplasia incidence in England, 2006-2020: a population-based trends analysis.2006 - 2020年英国HPV疫苗接种与宫颈癌筛查政策变化以及宫颈癌发病率和3级宫颈上皮内瘤变发病率之间的关联:一项基于人群的趋势分析
Lancet Reg Health Eur. 2024 Dec 10;49:101157. doi: 10.1016/j.lanepe.2024.101157. eCollection 2025 Feb.
2
Managing an extension of screening intervals: Avoiding boom and bust in health care workloads.管理筛查间隔的延长:避免医疗保健工作量的大起大落。
Int J Cancer. 2023 May 15;152(10):2061-2068. doi: 10.1002/ijc.34441. Epub 2023 Feb 1.

本文引用的文献

1
Primary cervical screening with high risk human papillomavirus testing: observational study.高危型人乳头瘤病毒检测用于宫颈癌初筛:观察性研究。
BMJ. 2019 Feb 6;364:l240. doi: 10.1136/bmj.l240.
2
Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?英格兰 20-24 岁年龄段女性宫颈癌发病率的近期上升是否值得关注?
Prev Med. 2018 Feb;107:21-28. doi: 10.1016/j.ypmed.2017.12.002. Epub 2017 Dec 13.
3
Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
根据筛查史评估60岁及以上女性宫颈筛查的有效性:瑞典全国队列研究
PLoS Med. 2017 Oct 24;14(10):e1002414. doi: 10.1371/journal.pmed.1002414. eCollection 2017 Oct.
4
Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.50至64岁的宫颈癌筛查与65岁及以上人群患宫颈癌的风险:基于人群的病例对照研究。
PLoS Med. 2014 Jan;11(1):e1001585. doi: 10.1371/journal.pmed.1001585. Epub 2014 Jan 14.
5
Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years.20-29 岁宫颈癌患者的特征和筛查史。
Br J Cancer. 2013 Jul 9;109(1):35-41. doi: 10.1038/bjc.2013.322. Epub 2013 Jul 2.
6
The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme.杰德·古迪的诊断和死亡对国民保健制度子宫颈筛查计划的影响。
J Med Screen. 2012 Jun;19(2):89-93. doi: 10.1258/jms.2012.012028. Epub 2012 May 31.
7
Cervical cancer screening in the United States and the Netherlands: a tale of two countries.美国和荷兰的宫颈癌筛查:两国的故事。
Milbank Q. 2012 Mar;90(1):5-37. doi: 10.1111/j.1468-0009.2011.00652.x.
8
The challenges of organising cervical screening programmes in the 15 old member states of the European Union.在欧盟15个老成员国组织宫颈癌筛查项目所面临的挑战。
Eur J Cancer. 2009 Oct;45(15):2671-8. doi: 10.1016/j.ejca.2009.07.016. Epub 2009 Aug 18.